CHROMOSOME DAMAGE AFTER 131I THERAPY

被引：0
作者：
不详
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1966年 / 275卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：786 / &
相关论文
共 50 条
  • [41] Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents
    Mairs, RJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (08) : 1171 - 1173
  • [42] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [43] Thyroid Cancer Therapy with 131I: A Comprehensive Review
    Rodriguez-Santiago, Stephanie
    Cantu, Ernesto
    Wagner, Robert
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [44] 131I IN THYROTOXICOSIS
    STAFFURTH, JS
    YOUNG, JA
    BMJ-BRITISH MEDICAL JOURNAL, 1967, 1 (5540): : 629 - +
  • [45] Release criteria for 131I therapy patients.
    Richard, ML
    HEALTH PHYSICS, 2002, 82 (06): : S193 - S193
  • [46] RADIATION THYROID CELLS AND 131I THERAPY - A HYPOTHESIS
    GREIG, WR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) : 1411 - +
  • [47] Study supports outpatient status for 131I therapy
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (06) : 28N - 28N
  • [48] FRACTIONATED 131I THERAPY IN LARGE TOXIC GOITRES
    SATERBOR.NE
    EINHORN, J
    ACTA ENDOCRINOLOGICA, 1966, 51 (01): : 7 - &
  • [49] Factors affecting 131I therapy radiation dose
    Nichols, Kenneth
    Tomas, Maria-Bernadette
    Tronco, Gene
    Leveque, Fritzgerald
    Bhargava, Kuldeep
    Palestro, Christopher
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [50] 131I tositumomab
    Culy, CR
    Lamb, HM
    BIODRUGS, 2000, 14 (03) : 195 - 202
12345